ResearcherSun Yat-sen UniversityActive in the last 2 years
Yong Wang
Matched on ORCID iD 0000-0002-8349-7555; OpenAlex author ID A5100424487. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 6
- A polymeric nanovesicle delivers sulfopin and gemcitabine to remodel tumor microenvironment for enhanced chemoimmunotherapy against orthotopic pancreatic cance… Last author DOI 10.1016/j.mtbio.2025.102153↗
- Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.actbio.2023.02.038↗
- A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer. Co-author DOI 10.1016/j.actbio.2023.08.007↗
- High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma. Co-author DOI 10.1038/s41598-022-22355-1↗
- Long-term effects of total vs. partial pancreatectomy among patients with pancreatic cancer: a population-based study. Co-author DOI 10.21037/atm-22-2217↗
- Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for the effective treatment of pancreatic can… Co-author DOI 10.1016/j.nano.2013.08.007↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rongze Wang · 2 shared papers, 2023–2025 · strength 0.48
- Paper A polymeric nanovesicle delivers sulfopin and gemcitabine to remodel tumor microenvironment for enhanced chemoimmunothe… DOI 10.1016/j.mtbio.2025.102153↗
- Paper A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote th… DOI 10.1016/j.actbio.2023.08.007↗
- Xintao Shuai · 3 shared papers, 2014–2023 · strength 0.42
- Paper A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote th… DOI 10.1016/j.actbio.2023.08.007↗
- Paper Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal … DOI 10.1016/j.actbio.2023.02.038↗
- Paper Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for t… DOI 10.1016/j.nano.2013.08.007↗
- Weiting Jiang · 1 shared paper, 2025 · strength 0.28
- Hong Ping Xiao · 1 shared paper, 2023 · strength 0.18
- Yun Wang · 1 shared paper, 2022 · strength 0.16
- Qi Liu · 1 shared paper, 2022 · strength 0.16
- Wenzhi Guo · 1 shared paper, 2022 · strength 0.16
- Shuijun Zhang · 1 shared paper, 2022 · strength 0.16
- Yun Zheng · 1 shared paper, 2022 · strength 0.13
- Andreas Minh Luu · 1 shared paper, 2022 · strength 0.13
- Zhiwen Yang · 1 shared paper, 2022 · strength 0.13
- Qiang Tao · 1 shared paper, 2022 · strength 0.13
- Lingmin Jiang · 1 shared paper, 2022 · strength 0.13
- Yinting Chen · 1 shared paper, 2014 · strength 0.04
- Qiubo Zhang · 1 shared paper, 2014 · strength 0.04
- Linjuan Zeng · 1 shared paper, 2014 · strength 0.04
- Kaihong Huang · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.